| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Financial Officer | SVP, Finance
3 companies
Quimi Daphne is a Chief Financial Officer at AMICUS THERAPEUTICS, INC. with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $5.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 9, 2018 | FOLD Amicus Therapeutics, Inc. | SVP, Finance | Sale+OE | 8,750 | $15.00 | $131,250.00 | -12.0% | |
| Mar 1, 2018 | FOLD Amicus Therapeutics, Inc. | SVP, Finance | Sale+OE | 8,149 | $14.06 | $114,536.64 | -11.2% | |
| Jan 2, 2018 | FOLD Amicus Therapeutics, Inc. | SVP, Finance | Sale+OE | 8,000 | $14.72 | $117,723.20 | -12.8% | |
| Oct 12, 2017 | FOLD Amicus Therapeutics, Inc. | SVP, Finance | Sale+OE | 7,000 | $14.25 | $99,739.50 | -11.3% |